Inventor · disambiguated record

Xinyao Du

Also filed as: DU XINYAO

30 granted patents·14 pending applications·745 citations·filing 2001–2024

97Inventor score

Technology areasA61K A61P C07C C07D C12N

Files withACUITAS THERAPEUTICS INC35 DERMIRA CANADA INC2 ALNYLAM PHARMACEUTICALS INC1 FLAGSHIP PIONEERING INNOVATIONS V INC1 KINETEK PHARMACEUTICALS INC1

Top patents by PatentIndex Score

44 records

0199US11648324B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·6 claims
0299US11634379B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·7 cites·25 claims
0399US11040112B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 22, 2021·26 cites·34 claims
0499US10723692B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·59 cites·34 claims
0599US10221127B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Mar 5, 2019·136 cites·51 claims
0699US10166298B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Jan 1, 2019·125 cites·39 claims
0799US9738593B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2015·Granted Aug 22, 2017·87 cites·47 claims
0899US9737619B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 22, 2017·78 cites·27 claims
0998US11453639B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·16 cites·23 claims
1098US11357856B2Lipids for delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·20 cites·20 claims
1198US11168051B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·20 cites·24 claims
1298US10106490B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2017·Granted Oct 23, 2018·71 cites·19 claims
1394US11712481B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 1, 2023·11 cites·35 claims
1494US11639329B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted May 2, 2023·6 cites·23 claims
1594US11542225B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jan 3, 2023·8 cites·24 claims
1694US11524932B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Dec 13, 2022·8 cites·24 claims
1793US11820728B2Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Nov 21, 2023·4 cites·26 claims
1893US9463247B2Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Oct 11, 2016·24 cites·29 claims
1992US12065396B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Aug 20, 2024·5 cites·18 claims
2092US2025034081A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2191US12129223B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·4 cites·26 claims
2291US11976019B2Cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·4 cites·27 claims
2385US2024075163A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
2481US2025084029A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2580US2024308952A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
2679US2025084030A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2776US8754233B2Pyrazolylbenzothiazole derivatives and their use as therapeutic agentsDERMIRA CANADA INC·Filed 2013·Granted Jun 17, 2014·2 cites·4 claims
2876US6514972B2Heteropolycyclic inhibitors of protein kinasesKINETEK PHARMACEUTICALS INC·Filed 2001·Granted Feb 4, 2003·8 cites·39 claims
2973US7847101B2Pyrazolylbenzothiazole derivatives and their use as therapeutic agentsVALOCOR THERAPEUTICS INC·Filed 2003·Granted Dec 7, 2010·6 cites·10 claims
3072US12410121B2Cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Granted Sep 9, 2025·0 cites·21 claims
3172US12151996B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2022·Granted Nov 26, 2024·0 cites·22 claims
3272US2025188020A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3371US2022204439A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
3470US2025236586A1Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3569US2024122854A1Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
3668US7196083B2Heteropolycyclic inhibitors of protein kinasesOLT INC·Filed 2002·Granted Mar 27, 2007·5 cites·12 claims
3767US12491261B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Granted Dec 9, 2025·0 cites·73 claims
3861US9434720B2Pyrazolylbenzothiazole derivatives and their use as therapeutic agentsDERMIRA (CANADA) INC·Filed 2014·Granted Sep 6, 2016·0 cites·16 claims
3961US2025025427A1Mixed amide ester containing lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
4059US2024270679A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
4156US2025375464A1Formulations for modulating myc expressionFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
4250US8410272B2Pyrazolylbenzothiazole derivatives and their use as therapeutic agentsZHANG ZAIHUI·Filed 2010·Granted Apr 2, 2013·0 cites·14 claims
4346US2019022247A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
4443US2018185516A1Delivery of target specific nucleasesSANGAMO THERAPEUTICS INC·Filed 2017·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Xinyao Du files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →